Learn more

L E A F HOLDINGS GROUP LLC

Overview
  • Total Patents
    96
  • GoodIP Patent Rank
    14,917
  • Filing trend
    ⇩ 91.0%
About

L E A F HOLDINGS GROUP LLC has a total of 96 patent applications. It decreased the IP activity by 91.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ARRYS THERAPEUTICS INC, GOLDHAM PHARMA GMBH and ASLAN PHARMACEUTICALS PTE LTD.

Patent filings per year

Chart showing L E A F HOLDINGS GROUP LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Niyikiza Clet 89
#2 Moyo Victor Mandla 50
#3 Moyo Victor 21
#4 Varghese Jose 10
#5 Khalifa Kaniz 8
#6 Xu Zhenghong 8
#7 Moyo Victor M 8
#8 Geng Bolin 7
#9 Clet Niyikiza 7
#10 Victor Mandla Moyo 5

Latest patents

Publication Filing date Title
WO2021026310A1 Processes of preparing polyglutamated antifolates and uses of their compositions
KR20210005244A Carotenoid composition and use thereof
CN111954529A Alpha polyglutamated methotrexate and uses thereof
WO2019157140A1 Gamma polyglutamated raltitrexed and uses thereof
EP3752158A1 Gamma polyglutamated aminopterin and uses thereof
CN111971047A Gamma polyglutamated tetrahydrofolic acid and application thereof
CN111936146A Alpha polyglutamated tetrahydrofolic acid and application thereof
CN111936145A Gamma polyglutamated methotrexate and uses thereof
EP3749315A1 Alpha polyglutamated raltitrexed and uses thereof
WO2019160734A1 Gamma polyglutamated lometrexol and uses thereof
CN111867593A Alpha polyglutamated antifolate agent and its use
US2020360388A1 Alpha polyglutamated pemetrexed and uses thereof
WO2019160736A1 Gamma polyglutamated pralatrexate and uses thereof
US2020360389A1 Gamma polyglutamated antifolates and uses thereof
KR20190051967A Polyglutamated antifolates and their uses
WO2018031980A1 Polyglutamated antifolates and uses thereof
WO2018031967A1 Polyglutamated antifolates and uses thereof
US2017319482A1 Targeted liposomal gemcitabine compositions and methods thereof
KR20170046145A Liposome encapsulated affinity drug